Franklin Berger

Franklin Berger

Direktör/Styrelseledamot på ATEA PHARMACEUTICALS, INC.

Förmögenhet: 7 M $ per 2026-10-31

76 år
Health Technology
Finance
Consumer Services

Profil

Mr. Franklin M.
Berger
, CFA MBA, is an Independent Director at Retension Pharmaceuticals, Inc., a Lead Independent Director at Atea Pharmaceuticals, Inc., a Senior Advisor at Qiming US Ventures Management, LLC and a Managing Director at FMB Research.
He is on the Board of Directors at Retension Pharmaceuticals, Inc., Satellos Bioscience, Inc., Atea Pharmaceuticals, Inc. and Walking Fish Therapeutics, Inc. Mr. Berger was previously employed as a Lead Independent Director by Rain Oncology, Inc., a Chairman by Proteostasis Therapeutics, Inc., an Independent Director by ESSA Pharma, Inc., an Independent Director by Atreca, Inc., an Independent Director by Tocagen, Inc., an Independent Director by Immune Design Corp., an Independent Director by BioTime, Inc., an Independent Director by Five Prime Therapeutics, Inc., an Independent Director by BELLUS Health, Inc., a Lead Independent Director by Thallion Pharmaceuticals, Inc., a Senior Manager-Portfolio by NEMO Fund, Inc., a Senior Manager-Investment by Sectoral Asset Management, Inc., an Independent Director by Seattle Genetics, Inc., a Managing Director-Equity Research by JPMorgan Securities, Inc., a Managing Director-Equity Research by Salomon Smith Barney, Inc., a Director-Equity Research by Smith Barney Asset Management, a Managing Director-Equity Research by Josephthal, Lyon & Ross, Inc., and an Advisor by Brookline Capital Acquisition Corp.
He also served on the board at Applied Therapeutics, Inc., Kezar Life Sciences, Inc., Emisphere Technologies, Inc., Isotechnika Pharma, Inc., Isotechnika, Inc., VaxGen, Inc., Alzheon, Inc., Asterias Biotherapeutics, Inc., Aurinia Pharmaceuticals, Inc., Caprion Proteomics, Inc., CellCarta Biosciences, Inc., Episcopal Relief & Development Corp., HealthShares, Inc., iTherX Pharmaceuticals, Inc., The Genetics Co., Inc. and ViroChem Pharma, Inc.

Kända innehav i offentliga företag

FöretagDatumAntal aktierVärderingVärderingsdatum
2026-08-18 690 067 ( 3,25 % ) 5 M $ 2026-10-31
2026-06-18 536 097 ( 0,67 % ) 2 M $ 2026-10-31
0,27 %
2026-10-13 22 517 ( 0,27 % ) 255 793 $ 2026-10-31

Aktiva positioner av Franklin Berger

FöretagPositionStart
ATEA PHARMACEUTICALS, INC. Direktör/Styrelseledamot 2019-09-01
SATELLOS BIOSCIENCE INC. Direktör/Styrelseledamot 2023-06-29
Verkställande Direktör 2005-06-01
Direktör/Styrelseledamot -
Konsult / Rådgivare 2019-01-01

Tidigare kända positioner av Franklin Berger

FöretagPositionSlut
KEZAR LIFE SCIENCES, INC. Direktör/Styrelseledamot 2026-05-11
ESSA PHARMA INC. Direktör/Styrelseledamot 2025-10-09
ATRECA, INC. Direktör/Styrelseledamot 2024-05-13
RAIN ONCOLOGY INC. Direktör/Styrelseledamot 2024-01-25
░░░░░░ ░░░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
Se detaljerna i Franklin Bergers erfarenhet

Franklin Bergers utbildningar

Erfarenheter
Innehade positioner

Aktiva

Inaktiva

Börsnoterade företag

Privata företag

Relationer

65

Första gradens relationer

41

Företag kopplade till första graden

Man

Kvinna

Styrelseledamöter

Chefer

Kopplade företag

Privata företag41

Health Technology

Health Technology

Distribution Services

Health Technology

Health Technology

Health Technology

Health Technology

Finance

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Finance

Finance

Finance

Consumer Services

Health Technology

Miscellaneous

Health Technology

Commercial Services

Health Technology

Health Services

Health Technology

Finance

Health Technology

Commercial Services

NEMO Fund, Inc.

Health Technology

Health Technology

Consumer Services

Health Technology

Miscellaneous

Health Technology

Health Technology

Health Technology

Finance

Health Technology

Finance

Health Technology

  1. Börsen
  2. Insiders
  3. Franklin Berger